Abstract:Objective: There are few prospective longitudinal studies in patients with newly diagnosed epilepsy (NDE) despite that this is a key time point to understand the underlying biology of epilepsy and to identify potential interventions and biomarkers for seizure and cognitive outcomes. Here we have performed a prospective combined neuroimaging and neuropsychological study in a cohort of patients with focal NDE and healthy controls. Methods: We recruited 104 patients with NDE and 45 healthy controls for research-grade 3 Tesla MRI (diagnostic and structural imaging, diffusional kurtosis imaging, resting-state functional MRI, task-based functional MRI), EEG, comprehensive neuropsychological, and blood biomarker investigations. We report here on the baseline clinical, neuroradiological, MRI morphometric, and neuropsychological findings in this cohort. Results: 38% of patients had unremarkable MRI features, 12% had lesions of known significance in epilepsy, 49% with abnormalities of unknown significance in epilepsy, and 23% with incidental findings. In comparison, 56% of controls had unremarkable MRI features, 7% had lesions of known significance in epilepsy, 33% with abnormalities of unknown significance in epilepsy, and 16% had incidental findings. Patients had a higher incidence of white matter hyperintensities compared to controls. Reduced bihemispheric frontal lobe cortical thickness and thalamic volumes were observed in patients with moderate effect sizes. Patients scored significantly lower on tasks of executive function, processing speed, and visual, delayed, and immediate memory, and significantly higher on depression and anxiety assessments compared to controls. Patient neuropsychological performance was related to various brain morphometric features. Significance: People with adult focal NDE have a greater proportion of MRI-positive findings than previously reported. Subtle white matter lesions may represent an important diagnostic criterion and have a pathophysiological basis in focal epilepsy. Morphometric and neuropsychological alterations are present at the point of diagnosis of epilepsy, which suggests that brain and cognitive changes are not exclusively due to the deleterious impact of chronic epilepsy.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: **Insufficient research on the neuroimaging and neuropsychological characteristics and their underlying biological mechanisms in patients with newly diagnosed focal epilepsy (NDE) in the early stage of the disease**. Specifically, the authors aim to fill the following gaps through prospective, longitudinal studies: 1. **Understanding the early biological mechanisms of epilepsy**: Although there have been many studies on long - term epilepsy, the biological mechanisms of newly diagnosed epilepsy patients have not been fully studied. This makes it difficult for us to apply the known knowledge of long - term epilepsy to newly diagnosed patients. 2. **Identifying potential interventions and biomarkers**: By conducting detailed neuroimaging and neuropsychological assessments on newly diagnosed epilepsy patients, researchers hope to find biomarkers related to epileptic seizures and cognitive outcomes, thus providing a basis for early intervention. 3. **Evaluating brain structure and function changes**: The study aims to determine whether there are early changes in brain structure and function in newly diagnosed epilepsy patients and to explore whether these changes are related to cognitive dysfunction. This is crucial for understanding the impact of epilepsy on the brain. 4. **Optimizing individualized management**: By conducting detailed neuroimaging and neuropsychological assessments on patients, researchers hope to be able to better predict patients' epilepsy control and cognitive function changes, thus achieving individualized treatment and management. ### Overview of research methods To achieve the above - mentioned goals, the researchers carried out the following work: - **Recruiting patients and control groups**: A total of 104 newly diagnosed focal epilepsy patients and 45 healthy control group participants were recruited. - **Multi - modal imaging examinations**: Including 3 Tesla MRI (diagnostic and structural imaging, diffusion kurtosis imaging, resting - state functional MRI, task - based functional MRI), EEG, etc. - **Neuropsychological assessment**: Using multiple standardized tools to assess cognitive functions, including memory, executive function, processing speed, etc. - **Blood biomarker analysis**: Collecting blood samples to analyze cell damage and inflammation markers. ### Main findings - **High proportion of MRI abnormalities**: 61% of patients had abnormal MRI reports, while 44% in the control group. Among the patients, 38% had no obvious abnormal MRI features, 12% had lesions known to be related to epilepsy, and 49% had abnormalities of unknown significance. - **Increased white matter hyperintensities**: The proportion of white matter hyperintensities in patients was significantly higher than that in the control group. - **Reduced bilateral frontal cortex thickness**: Patients showed a significant reduction in bilateral frontal cortex thickness, especially in the left pre - central gyrus and middle frontal gyrus. - **Impaired cognitive function**: Patients' performance in executive function, processing speed, and visual, delayed and immediate memory was significantly lower than that of the control group, and their anxiety and depression scores were higher. ### Conclusion This study shows that patients with newly diagnosed focal epilepsy already have changes in brain structure and cognitive function at the time of diagnosis, and these changes may not be caused by chronic epilepsy, but are related to the early pathophysiological process of the disease. Therefore, early intervention and personalized treatment are of great significance for improving the prognosis of patients. ### Examples of formula presentation When discussing specific statistical analyses, the paper mentioned some formulas, such as the method of calculating the z - score: \[ z=\frac{\text{score}-\text{mean}(100\times\text{mean(scores for 10 controls)})}{\text{mean}(100\times\text{sd(scores for 10 controls)})} \] In addition, Cohen's d was also used to calculate the effect size: \[ d = \frac{\bar{x}_1-\bar{x}_2}{s_p} \] where \(\bar{x}_1\) and \(\bar{x}_2\) are the means of the two groups respectively, and \(s_p\) is the pooled standard deviation. Through these methods, researchers can more accurately assess the differences between patients and the control group.

Prospective neuroimaging and neuropsychological evaluation in adults with newly diagnosed focal epilepsy

Neuroimaging characteristics of MRI-negative orbitofrontal epilepsy with focus on voxel-based morphometric MRI postprocessing.

Linking Mri Postprocessing with Magnetic Source Imaging in Mri-Negative Epilepsy

Subcortical alterations in newly diagnosed epilepsy and associated changes in brain connectivity and cognition

A prospective pilot study of cognitive impairment and mood in adults with first seizure, new-onset epilepsy, and newly diagnosed epilepsy at time of initial seizure presentation

Long-term cognitive outcomes in patient with epilepsy

Multimodal noninvasive evaluation in MRI-negative operculoinsular epilepsy.

Association of cognitive and structural correlates of brain aging and incident epilepsy. The Framingham Heart Study

Incidence and impact of subclinical epileptiform activity in Alzheimer's disease

Cognitive Impairment in MRI-Negative Epilepsy: Relationship between Neurophysiological and Neuropsychological Measures

Clinical prediction models for treatment outcomes in newly diagnosed epilepsy: A systematic review

The network is more important than the node: stereo-EEG evidence of neurocognitive networks in epilepsy

Neuroimaging of memory in frontal lobe epilepsy

Neuropsychological function in psychosis of epilepsy

Memory processes and prefrontal network dysfunction in cryptogenic epilepsy

Neuropsychological outcomes after epilepsy surgery: A comparison of stereo electroencephalography and subdural electrodes

Neuroimaging Biomarkers of Experimental Epileptogenesis and Refractory Epilepsy

Brain structure and organization five decades after childhood onset epilepsy

Memory compromise at extended delays in people with new-onset epilepsy

Neuropsychological profiles and outcomes in children with new onset frontal lobe epilepsy